Many clinical observations have indicated that the growth of mammary cancer in women is accelerated by pregnancy and lactation (1,2). The effect of lactation alone is not known, although Geschickter (3) believes that it does not influence the growth rate of in filtrating cancer of the breast. Pregnancy stimulation is usually ascribed to the high estrogen titre, a situation which does not apply during lactation(3). In mice, estrogens exert a carcinogenic effect on the mammary gland (4), but the estrogen preponderance of pregnancy apparently does not accelerate the tumor growth(5). The influence of lactation, with its high lactogenic titre, has not been established, although it has been shown that a crude prolactin preparation did not modify the growth rate of these tumors (6). With the recent availability of homogeneous pituitary lactogenic hormone, it was thought worth while to test this substance for its possible effect upon the growth of mammary adenocarcinoma in mice. Procedure. Virgin female mice of the C3H strain, 5 to 6 months old, were used. To obviate any ovarian influence half the group was oophorectomized. After a 7 week recovery period, uniform fragments of a transplantable C3H strain mammary adenocarcinoma were implanted by trocar in the dorsal subcutaneous tissues. Eight days later subcutaneous injections were begun. Half of each group, castrated and intact, received two 0.1 cc injections daily, each containing 1 mg of purified lactogenic hormone assaying 30 I.U. per mg(7). The control groups received equal volumes of normal saline. Periodic recordings were made of body weights and tumor diameters. Daily vaginal smears of the hormone-treated mice showed anestrous periods of 12 to 15 days occurred regularly throughout the experiment, thus demonstrating the continued potency of the hormone.
Read full abstract